Question 1

How does EquitAI evaluate The Taiwan Fund, Inc.'s (TWN) valuation and Stock DNA?

Accepted Answer

The Taiwan Fund, Inc. (TWN) trades at $86.47 with an EquitAI Valuation DNA score of 6/10 and Quality score of 5/10. The company's trailing P/E ratio is 2.2x. These scores evaluate balance sheet leverage, free cash flow generation, and fundamental multiples against historical benchmarks.

Question 2

What sector and industry does The Taiwan Fund, Inc. (TWN) operate in?

Accepted Answer

The Taiwan Fund, Inc. (TWN) is classified under the Financial Services sector within the Asset Management industry. EquitAI benchmarks its fundamental valuation and financial DNA metrics against both direct Asset Management peers and broader Financial Services market benchmarks.

Question 3

Does TWN pay dividends or capital distributions?

Accepted Answer

The Taiwan Fund, Inc. has an indicated annual dividend yield of 7.17%. Dividend stability is factored into its Income DNA pillar alongside free cash flow coverage.

Question 4

Who are The Taiwan Fund, Inc.'s (TWN) primary market competitors and peers?

Accepted Answer

Key market peers and semantic competitors include IFN, HEQ, CRF, TDF. EquitAI maps peer relationships through semantic business models, institutional capital flow correlation, and market capitalization weighting.

Question 5

How should investors interpret EquitAI's TWN analysis?

Accepted Answer

EquitAI provides quantitative financial research, algorithmic DNA scores, and SEC contextual analytics for informational and research purposes. It does not constitute personalized financial advice or broker-dealer investment recommendations.

TWN - The Taiwan Fund, Inc. Stock Analysis & Valuation

The Taiwan Fund, Inc.

FIT ANALYSIS